Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Systematic Review

Published on 16 Feb 2024

Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

John Hang Leung
Shyh-Yau Wang
Henry W. C. Leung
Agnes L. F. Chan

Frontiers in Oncology

doi 10.3389/fonc.2024.1344798

4,972 views
7 citations

Original Research

Published on 09 Feb 2024

Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Philipp Berning
Adrian E. Schroer
Rishav Adhikari
Alexander C. Razavi
Francois H. Cornelis
Joseph P. Erinjeri
Stephen B. Solomon
Debkumar Sarkar
Hebert Alberto Vargas
Heiko Schöder

Frontiers in Oncology

doi 10.3389/fonc.2024.1324095

1,623 views
1 citation

Original Research

Published on 08 Feb 2024

Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuan-Zhang Wen
Gao-Min Liu
Jia-Peng Liao
Ji-Wei Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1294253

1,676 views
4 citations

Systematic Review

Published on 08 Feb 2024

Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kaifeng Su
Ruifeng Duan
Yang Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1331706

1,424 views
3 citations

Original Research

Published on 08 Feb 2024

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Afsaneh Barzi
Caroline M. Weipert
Carin R. Espenschied
Victoria M. Raymond
Andrea Wang-Gillam
Mohammad Amin Nezami
Eva J. Gordon
Daruka Mahadevan
Kabir Mody

Frontiers in Oncology

doi 10.3389/fonc.2024.1339302

4,184 views
2 citations

Case Report

Published on 07 Feb 2024

Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ruobing Qi
Wenhua Yang
Sixian Zhu
Jie Mao
Bei Yang
Anhui Xu
Qiang Fu

Frontiers in Oncology

doi 10.3389/fonc.2024.1278340

1,384 views
2 citations

Correction

Published on 07 Feb 2024

Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuan Feng
Junjun Yang
Wentao Duan
Yu Cai
Xiaohong Liu
Yong Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1370998

871 views

Original Research

Published on 07 Feb 2024

A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Honghai Zhang
Shugui Sheng
Wenying Qiao
Ming Han
Ronghua Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1340286

1,505 views
2 citations

Case Report

Published on 06 Feb 2024

Massive extrapancreatic solid pseudopapillary neoplasm misdiagnosed as hepatic tumor: a case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jixu Guo
Qingjuan Zhao
Liting Qin
Shengjie Xie
Shiliu Lu
Baibei Li
Meilin He
Linhong Xie
Shuiping Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1342400

1,241 views

Case Report

Published on 06 Feb 2024

Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kai Cui
Zhongchao Li
Jingtao Zhong
Xuetao Shi
Lei Zhao
Hao Li
Ying Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1355798

1,694 views

Case Report

Published on 31 Jan 2024

Complete remission of gallbladder neuroendocrine carcinoma with liver metastasis by tislelizumab plus chemotherapy: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huafei Li
Jiaming Qiao
Xiaoxia Kou
Cong Wu
Huiying Liu
Jinrong Qiu

Frontiers in Oncology

doi 10.3389/fonc.2024.1346290

2,225 views
1 citation

Case Report

Published on 31 Jan 2024

Primary gastrinoma of the gallbladder: a case report and review of the literature

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yao-Ge Liu
Shi-Tao Jiang
Yang Zhou
Jun-Wei Zhang
Xin-Ting Sang
Lei Zhang
Xin Lu
Yi-Yao Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1279766

1,578 views

Original Research

Published on 30 Jan 2024

Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Sungmo Moon
Gyoung Min Kim
Jong Yun Won
Joon Ho Kwon
Juil Park
Kichang Han
Man-Deuk Kim
Hyung Cheol Kim
Dong Kyu Kim
Jin Young Choi

Frontiers in Oncology

doi 10.3389/fonc.2024.1349632

997 views

Review

Published on 29 Jan 2024

Application of AI on cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jianhao Huang
Xuesong Bai
Yanyu Qiu
Xiaodong He

Frontiers in Oncology

doi 10.3389/fonc.2024.1324222

3,334 views
4 citations

Original Research

Published on 23 Jan 2024

Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitors

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yiwan Guo
Wenlong Wu
Bo Sun
Tingting Guo
Keke Si
Chuansheng Zheng
Xin Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1293680

1,388 views

Original Research

Published on 22 Jan 2024

The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhongjing Huang
Ziyi Wu
Lidong Zhang
Likun Yan
Hai Jiang
Junhua Ai

Frontiers in Oncology

doi 10.3389/fonc.2024.1298122

2,859 views
6 citations